Memo Therapeutics raised €20M in a Series C round in May 2024. The company is based in Zurich, Switzerland. Investors in the round: Kurma Partners, Ysios Capital. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
